“DEPO MEDROKSI PROGESTERON ASETAT (DMPA) INCREASES BODY MASS INDEX OF ACCEPTORS BUT DECREASES THEIR LIBIDO”. Proceedings of the International Conference on Applied Science and Health, no. 2, Sept. 2017, pp. 81-85, https://publications.inschool.id/index.php/icash/article/view/880.